Safety and Efficacy Study Using Bevacizumab, Capecitabine and Oxaliplatin for Colorectal Cancer

NCT00177307 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Cancer

Interventions

DRUG: Bevacizumab
DRUG: Capecitabine
DRUG: Oxaliplatin

Sponsor

University of Pittsburgh

Collaborators

[object Object]